SPRC
Scisparc Provides Updates on Status of Spin-off of Its Advanced Clinical Stage Pharmaceutical Portfolio to a Publicly Traded Company
时间：2024-12-16 20:40:00 市场： 美股 综合
Scisparc Ltd: Entered Into Second Addendum to Merger Agreement With Automax Motors Ltd and Scisparc Merger Sub Ltd
时间：2024-11-28 05:54:16 市场： 美股 综合
Scisparc Ltd: Right to Terminate Merger Agreement IF Merger Was Not Consummated by Nov 30, 2024, Was Deferred to March 31, 2025
时间：2024-11-28 05:54:16 市场： 美股 综合
Scisparc Secures FDA Green Light to US Launch of Its Pivotal Phase Iib Clinical Trial for Breakthrough Tourette Syndrome Treatment
时间：2024-09-30 21:25:00 市场： 美股 综合
Scisparc Signs Non-Binding Letter of Intent to Sell Stake in Mitocarex
时间：2024-09-26 21:05:00 市场： 美股 综合
Scisparc Ltd - Owns 52.73% of Mitocarex
时间：2024-09-26 21:05:00 市场： 美股 综合
Scisparc Receives FDA Approval to Initiate Phase Iib Clinical Trial for Tourette Syndrome Treatment
时间：2024-09-23 20:17:00 市场： 美股 综合
Scisparc Ltd - FDA Confirms Scisparc's Study May Proceed
时间：2024-09-23 20:17:00 市场： 美股 综合
Scisparc Takes Major Step Forward With Ind Application Submitted to the FDA for Phase Iib Clinical Trial for Tourette Syndrome Treatment
时间：2024-09-19 04:09:00 市场： 综合 美股
Scisparc Advances $1.85 Million Loan to Automax, Following Automax’s Direct Import Agreement With Major Chinese Vehicle Manufacturer
时间：2024-09-11 19:40:00 市场： 美股 综合